The seminars will be implemented in close cooperation of DZIF with the D SOLVE Academy and involve leading European virologists, immunologists and hepatologists.
Speaker
Dr. Katrin Wisskirchen (SCG Cell Therapy GmbH, Planegg/Germany)
“Clinical application of gene modified HBV specific T cells for treatment of HBV induced HCC.”
Time
November 25, 2024 at 5 p.m.
Location
Medical School Hannover
Building J01 - lecture hall M
Online participation
The seminar will be available as a Microsoft Teams webinar.
ID: 375 730 822 417| Code: JuW7tz
Organizers
- Prof. Heiner Wedemeyer
- Dr. Carola Kaienburg
- Dr. Jennifer Debarry
Contact
Project Management Team D-SOLVE